Home » Topics » Regulatory » Patents

Patents
RSS

Medshine Discovery identifies new RIP-1 inhibitors

Dec. 16, 2020

Merck & Co. patents NPR1 agonists

Dec. 16, 2020

Voronoi discloses new RET inhibitors

Dec. 16, 2020

Suzhou Ribo Life Science describes new PCSK9-targeting siRNA

Dec. 15, 2020

BioTheryX presents new GSPT1 inhibitors

Dec. 15, 2020

Gilead Sciences identifies MAP4K1 inhibitors

Dec. 15, 2020

U.S. researchers synthesize new KRAS mutant inhibitors

Dec. 15, 2020

Voronoi patents FLT3 and/or MAP4K1 and/or CDK6/cyclin D1 inhibitors

Dec. 15, 2020

Suzhou Ribo Life Science patents FXI-targeting siRNA

Dec. 14, 2020

Boryung Pharmaceutical describes new PI3Kdelta and/or DNA-PK inhibitors

Dec. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...